IRCT20200217046520N2已完成Unknown
Investigating the effect of anti-reflux mucosal ablation (ARMA) in reducing the symptoms of esophageal reflux (GERD) in patients resistant to treatment with proton pump inhibitors (PPI)
适应症
试验速览
- 阶段
- Unknown
- 状态
- 已完成
- 入组人数
- 48
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 65 years（—）
- 性别
- All
入选标准
- •Age between 20 and 65 years
- •At least one typical symptom of reflux more than twice a week
- •Sliding hiatal hernia
- •Hill grade minimum I and maximum III
排除标准
- •Primary motility disorders of the esophagus
- •Hiatal hernia sliding more than 3 cm
- •Hill grade IV
研究者
相似试验
招募中
不适用
Efficacy and safety of Anti-reflux mucosal ablation for refractory GERD: Multi-center prospective study.PPI/PCAB refractory/dependent GERDJPRN-UMIN000045188Showa University Koto Toyosu Hospital, Digestive Diseases Center100
尚未招募
Unknown
Endoscopic anti-reflux treatment for those with reflux disease after gastric sleeve surgeryGastroesophageal reflux diseaseOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonACTRN12623000462684Royal Prince Alfred Hospital20
尚未招募
不适用
Endoscopic treatment for gastroesophageal reflux diseaseDiseases of the digestive systemKCT0003938Asan Medical Center10
终止
不适用
Effect of Antireflux Therapy on the Expression of Genes in Patients With GERDGERDGastroesophageal RefluxNCT00624546University of Rochester24
已完成
早期 1 期
Evaluation of the effect of mucodentol on people with coronavirusCOVID-19.COVID-19U07.1IRCT20130428013151N2Khoram-Abad University of Medical Sciences200